Document Detail


Changes of cerebral biopterin and biogenic amine metabolism in leukemic children receiving 5 g/m2 intravenous methotrexate.
MedLine Citation:
PMID:  7537364     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Acute or subacute neurologic disorders can be observed in patients receiving high-dose methotrexate therapy for lymphoblastic leukemia or malignant tumor. Impairment of biopterin metabolism leading to decreased availability of monoamine neurotransmitters has been suggested to explain methotrexate neurotoxicity. To investigate such a mechanism, we have measured prospectively by HPLC the concentrations of total biopterin, homovanillic acid, and 5-hydroxyindolacetic acid in cerebrospinal fluid of 57 children with acute lymphoblastic leukemia. A sequential analysis of cerebrospinal fluid was performed for each patient: cerebrospinal fluid samples were obtained before therapy and after each of the four high-dose methotrexate infusions during the CNS prophylaxis phase. A significant increase of total biopterin concentrations in cerebrospinal fluid was observed after high-dose methotrexate therapy compared with the pretreatment values. No cumulative effect was noted. In contrast, no significant variation of the homovanillic acid and 5-hydroxyindolacetic acid levels was observed in cerebrospinal fluid. However, individual analysis revealed a transient decrease of homovanillic acid and 5-hydroxyindolacetic acid concentrations in cerebrospinal fluid of six children. The increase of total biopterin mimicking that observed in inherited dihydropteridine reductase deficiencies suggests that methotrexate inhibits the regenerating system of biopterin in the brain of patients undergoing high-dose methotrexate therapy.
Authors:
F Millot; J L Dhondt; F Mazingue; F Mechinaud; P Ingrand; F Guilhot
Related Documents :
3128644 - Intracerebroventricular administration of 1-methyl-4-phenylpyridinium ion in mice: effe...
21112364 - The nutritive value of grasspea (lathyrus sativus) and allied species, their toxicity t...
6193764 - Csf and urinary biogenic amines and metabolites in depression and mania. a controlled, ...
4209434 - Orosomucoid content of pleural and peritoneal effusions.
24884764 - Secondary bile acids: an underrecognized cause of colon cancer.
9336884 - Elevated levels of beta-hydroxybutyric acid in periparturient cows and in vitro effect ...
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  Pediatric research     Volume:  37     ISSN:  0031-3998     ISO Abbreviation:  Pediatr. Res.     Publication Date:  1995 Feb 
Date Detail:
Created Date:  1995-05-30     Completed Date:  1995-05-30     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0100714     Medline TA:  Pediatr Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  151-4     Citation Subset:  IM    
Affiliation:
Service d'Hématologie et Oncologie Médicale, CHU, Poitiers, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
6-Mercaptopurine / administration & dosage
Adolescent
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Biogenic Amines / cerebrospinal fluid*
Biopterin / cerebrospinal fluid*
Brain Chemistry / drug effects*
Child
Child, Preschool
Chromatography, High Pressure Liquid
Cytarabine / administration & dosage
Dihydropteridine Reductase / antagonists & inhibitors,  metabolism
Female
Homovanillic Acid / cerebrospinal fluid
Humans
Hydroxyindoleacetic Acid / cerebrospinal fluid
Infant
Infusions, Intravenous
Male
Methotrexate / administration & dosage,  pharmacology*
Nerve Tissue Proteins / antagonists & inhibitors,  metabolism
Precursor Cell Lymphoblastic Leukemia-Lymphoma / cerebrospinal fluid*,  drug therapy
Prospective Studies
Chemical
Reg. No./Substance:
0/Biogenic Amines; 0/Nerve Tissue Proteins; 147-94-4/Cytarabine; 22150-76-1/Biopterin; 306-08-1/Homovanillic Acid; 50-44-2/6-Mercaptopurine; 54-16-0/Hydroxyindoleacetic Acid; 59-05-2/Methotrexate; EC 1.5.1.34/Dihydropteridine Reductase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transcription elongation of the murine ornithine decarboxylase (ODC) gene is regulated in vitro at t...
Next Document:  Transient elevation of granulocyte colony-stimulating factor levels in cerebrospinal fluid at the in...